Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Fragment-Based Drug Discovery market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 14.7% during the forecast period.
This report presents the market size and development trends by detailing the Fragment-Based Drug Discovery market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Fragment-Based Drug Discovery market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Fragment-Based Drug Discovery industry and will help you to build a panoramic view of the industrial development.
Fragment-Based Drug Discovery Market, By Type:
NMR Spectroscopy
DSF Assay
Fluorescence Polarization (FP)
Isothermal Titration Calorimetry (ITC)
X-ray Crystallography
Fragment-Based Drug Discovery Market, By Application:
Biopharmaceutical Companies
CROs
Academic and Research Institutions
Some of the leading players are as follows:
Proteros Fragments GmbH
Alveus Pharmaceuticals Pvt. Ltd
Crown Bioscience, Inc
Emerald BioStructures, Inc
Kinetic Discovery Limited
Alveus Pharmaceuticals Pvt Ltd
Astex Pharmaceuticals
Evotec AG
Structure Based Design, Inc
Sprint Bioscience
Beactica AB
Charles River Laboratories International, Inc
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Fragment-Based Drug Discovery Market: Technology Type Analysis
-
4.1 Fragment-Based Drug Discovery Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Fragment-Based Drug Discovery Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 NMR Spectroscopy
4.3.2 DSF Assay
4.3.3 Fluorescence Polarization (FP)
4.3.4 Isothermal Titration Calorimetry (ITC)
4.3.5 X-ray Crystallography
5 Fragment-Based Drug Discovery Market: Product Analysis
-
5.1 Fragment-Based Drug Discovery Product Market Share Analysis, 2018 & 2026
-
5.2 Fragment-Based Drug Discovery Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Fragment-Based Drug Discovery Market: Application Analysis
-
6.1 Fragment-Based Drug Discovery Application Market Share Analysis, 2018 & 2026
-
6.2 Fragment-Based Drug Discovery Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Biopharmaceutical Companies
6.3.2 CROs
6.3.3 Academic and Research Institutions
7 Fragment-Based Drug Discovery Market: Regional Analysis
-
7.1 Fragment-Based Drug Discovery Regional Market Share Analysis, 2018 & 2026
-
7.2 Fragment-Based Drug Discovery Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Proteros Fragments GmbH
9.1.1 Proteros Fragments GmbH Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Alveus Pharmaceuticals Pvt. Ltd
9.2.1 Alveus Pharmaceuticals Pvt. Ltd Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 Crown Bioscience, Inc
9.3.1 Crown Bioscience, Inc Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Emerald BioStructures, Inc
9.4.1 Emerald BioStructures, Inc Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Kinetic Discovery Limited
9.5.1 Kinetic Discovery Limited Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Alveus Pharmaceuticals Pvt Ltd
9.6.1 Alveus Pharmaceuticals Pvt Ltd Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Astex Pharmaceuticals
9.7.1 Astex Pharmaceuticals Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Evotec AG
9.8.1 Evotec AG Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Structure Based Design, Inc
9.9.1 Structure Based Design, Inc Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 Sprint Bioscience
9.10.1 Sprint Bioscience Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
9.11 Beactica AB
9.11.1 Beactica AB Company overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.11.5 SWOT analysis
9.12 Charles River Laboratories International, Inc
9.12.1 Charles River Laboratories International, Inc Company overview
9.12.2 Financial performance
9.12.3 Product benchmarking
9.12.4 Strategic initiatives
9.12.5 SWOT analysis
The List of Tables and Figures (Totals 77 Figures and 132 Tables)
Figure NMR Spectroscopy Fragment-Based Drug Discovery market, 2015 - 2026 (USD Million)
Figure DSF Assay Fragment-Based Drug Discovery market, 2015 - 2026 (USD Million)
Figure Fluorescence Polarization (FP) Fragment-Based Drug Discovery market, 2015 - 2026 (USD Million)
Figure Isothermal Titration Calorimetry (ITC) Fragment-Based Drug Discovery market, 2015 - 2026 (USD Million)
Figure X-ray Crystallography Fragment-Based Drug Discovery market, 2015 - 2026 (USD Million)
Figure Biopharmaceutical Companies market, 2015 - 2026 (USD Million)
Figure CROs market, 2015 - 2026 (USD Million)
Figure Academic and Research Institutions market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Fragment-Based Drug Discovery market, by country, 2015 - 2026 (USD Million)
-
Table North America Fragment-Based Drug Discovery market, by type, 2015 - 2026 (USD Million)
-
Table North America Fragment-Based Drug Discovery market, by product, 2015 - 2026 (USD Million)
-
Table North America Fragment-Based Drug Discovery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Fragment-Based Drug Discovery market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Fragment-Based Drug Discovery market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Fragment-Based Drug Discovery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Fragment-Based Drug Discovery market, by type, 2015 - 2026 (USD Million)
-
Table Canada Fragment-Based Drug Discovery market, by product, 2015 - 2026 (USD Million)
-
Table Canada Fragment-Based Drug Discovery market, by application, 2015 - 2026 (USD Million)
-
Table Europe Fragment-Based Drug Discovery market, by country, 2015 - 2026 (USD Million)
-
Table Europe Fragment-Based Drug Discovery market, by type, 2015 - 2026 (USD Million)
-
Table Europe Fragment-Based Drug Discovery market, by product, 2015 - 2026 (USD Million)
-
Table Europe Fragment-Based Drug Discovery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Fragment-Based Drug Discovery market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Fragment-Based Drug Discovery market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Fragment-Based Drug Discovery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Fragment-Based Drug Discovery market, by type, 2015 - 2026 (USD Million)
-
Table Germany Fragment-Based Drug Discovery market, by product, 2015 - 2026 (USD Million)
-
Table Germany Fragment-Based Drug Discovery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Fragment-Based Drug Discovery market, by type, 2015 - 2026 (USD Million)
-
Table France Fragment-Based Drug Discovery market, by product, 2015 - 2026 (USD Million)
-
Table France Fragment-Based Drug Discovery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Fragment-Based Drug Discovery market, by type, 2015 - 2026 (USD Million)
-
Table Italy Fragment-Based Drug Discovery market, by product, 2015 - 2026 (USD Million)
-
Table Italy Fragment-Based Drug Discovery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Fragment-Based Drug Discovery market, by type, 2015 - 2026 (USD Million)
-
Table Spain Fragment-Based Drug Discovery market, by product, 2015 - 2026 (USD Million)
-
Table Spain Fragment-Based Drug Discovery market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Fragment-Based Drug Discovery market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Fragment-Based Drug Discovery market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Fragment-Based Drug Discovery market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Fragment-Based Drug Discovery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Fragment-Based Drug Discovery market, by type, 2015 - 2026 (USD Million)
-
Table China Fragment-Based Drug Discovery market, by product, 2015 - 2026 (USD Million)
-
Table China Fragment-Based Drug Discovery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Fragment-Based Drug Discovery market, by type, 2015 - 2026 (USD Million)
-
Table Japan Fragment-Based Drug Discovery market, by product, 2015 - 2026 (USD Million)
-
Table Japan Fragment-Based Drug Discovery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Fragment-Based Drug Discovery market, by type, 2015 - 2026 (USD Million)
-
Table India Fragment-Based Drug Discovery market, by product, 2015 - 2026 (USD Million)
-
Table India Fragment-Based Drug Discovery market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Fragment-Based Drug Discovery market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Fragment-Based Drug Discovery market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Fragment-Based Drug Discovery market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Fragment-Based Drug Discovery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Fragment-Based Drug Discovery market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Fragment-Based Drug Discovery market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Fragment-Based Drug Discovery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Fragment-Based Drug Discovery market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Fragment-Based Drug Discovery market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Fragment-Based Drug Discovery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Fragment-Based Drug Discovery market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Fragment-Based Drug Discovery market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Fragment-Based Drug Discovery market, by application, 2015 - 2026 (USD Million)
-
Table MEA Fragment-Based Drug Discovery market, by country, 2015 - 2026 (USD Million)
-
Table MEA Fragment-Based Drug Discovery market, by type, 2015 - 2026 (USD Million)
-
Table MEA Fragment-Based Drug Discovery market, by product, 2015 - 2026 (USD Million)
-
Table MEA Fragment-Based Drug Discovery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Fragment-Based Drug Discovery market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Fragment-Based Drug Discovery market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Fragment-Based Drug Discovery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Fragment-Based Drug Discovery market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Fragment-Based Drug Discovery market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Fragment-Based Drug Discovery market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Proteros Fragments GmbH Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Alveus Pharmaceuticals Pvt. Ltd Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Crown Bioscience, Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Emerald BioStructures, Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Kinetic Discovery Limited Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Alveus Pharmaceuticals Pvt Ltd Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Astex Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Evotec AG Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Structure Based Design, Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Sprint Bioscience Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Beactica AB Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Charles River Laboratories International, Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
